Variant of transcription factor 7-like 2 ( TCF7L2 ) gene confers risk of type 2 diabetes

We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription fact...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 38; no. 3; pp. 320 - 323
Main Authors Grant, Struan F A, Stefansson, Kari, Thorleifsson, Gudmar, Reynisdottir, Inga, Benediktsson, Rafn, Manolescu, Andrei, Sainz, Jesus, Helgason, Agnar, Stefansson, Hreinn, Emilsson, Valur, Helgadottir, Anna, Styrkarsdottir, Unnur, Magnusson, Kristinn P, Walters, G Bragi, Palsdottir, Ebba, Jonsdottir, Thorbjorg, Gudmundsdottir, Thorunn, Gylfason, Arnaldur, Saemundsdottir, Jona, Wilensky, Robert L, Reilly, Muredach P, Rader, Daniel J, Bagger, Yu, Christiansen, Claus, Gudnason, Vilmundur, Sigurdsson, Gunnar, Thorsteinsdottir, Unnur, Gulcher, Jeffrey R, Kong, Augustine
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group 01.03.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 × 10−9). This was replicated in a Danish cohort (P = 4.8 × 10−3) and in a US cohort (P = 3.3 × 10−9). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1061-4036
1546-1718
DOI:10.1038/ng1732